Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Exelixis (EXEL) is now available.
At Exelixis, Inc.’s 2024 Annual Meeting, shareholders voted to expand the Employee Stock Purchase Plan, authorizing an additional 6 million shares for issuance. The board of directors saw the re-election of 11 members, and Ernst & Young LLP was ratified as the independent accounting firm for the upcoming fiscal year. Additionally, the compensation of Exelixis’ executive officers received advisory approval from the stockholders. These decisions reflect the active engagement of Exelixis’ investors in the company’s governance and strategic incentive programs.
For an in-depth examination of EXEL stock, go to TipRanks’ Stock Analysis page.

